Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancer
Ying Zhu(Jiangsu Cancer Hospital), Jinhai Tang(Nanjing University of Chinese Medicine)
Cited by 19
Related Papers
Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines
|Molecular Medicine Reports|2014|59